Analytical and Clinical Validation of AIM-NASH: A Digital Pathology Tool for Artificial Intelligence-based Measurement of Nonalcoholic Steatohepatitis Histology
Pulaski, H.; Harrison, S. A.; Mehta, S. S.; Sanyal, A. J.; Vitali, M. C.; Manigat, L. C.; Hou, H.; Madasu Christudoss, S. P.; Hoffman, S. M.; Stanford-Moore, A.; Egger, R.; Glickman, J.; Resnick, M.; Patel, N.; Taylor, C. E.; Myers, R. P.; Chung, C.; Patterson, S. D.; Sejling, A.-S.; Minnich, A.; Baxi, V.; Subramaniam, G. M.; Anstee, Q. M.; Loomba, R.; Ratziu, V.; Montalto, M. C.; Beck, A. H.; Wack, K.
Show abstract
Metabolic-dysfunction associated steatohepatitis (MASH) is a major cause of liver-related morbidity and mortality, yet treatment options are limited. Manual scoring of liver biopsies, currently the gold standard for clinical trial enrollment and endpoint assessment, suffers from high reader variability. This study represents the most comprehensive multi-site analytical and clinical validation of an AI-based pathology system, Artificial Intelligence-based Measurement of Nonalcoholic Steatohepatitis (AIM-NASH), to assist pathologists in MASH trial histology scoring. AIM-NASH demonstrated high repeatability and reproducibility compared to manual scoring. AIM-NASH-assisted reads by expert MASH pathologists were superior to unassisted reads in accurately assessing inflammation, ballooning, NAS >= 4 with >=1 in each score category, and MASH resolution, while maintaining non-inferiority in steatosis and fibrosis assessment. These findings suggest AIM-NASH could mitigate reader variability, providing a more reliable assessment of therapeutics in MASH clinical trials.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predicting Short-Term Mortality in Severe Cirrhosis: An Interpretable Machine Learning Model Integrating Routine Clinical Indicators 92%
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study 92%
- LIMPACAT : Multi-Omics Attention Transformer for Immune Prediction in Liver Cancer Using Whole-Slide Imaging 92%
Similar papers in this journal
- AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH, and AIH 94%
- Lymphoid Enhancer-Binding Factor 1 (LEF1) immunostaining as a surrogate of β-catenin ( CTNNB1) mutations 87%
- Increasing both specificity and sensitivity of SARS-CoV-2 antibody tests by using an adaptive orthogonal testing approach 87%
Similar papers in this journal
Similar papers in this journal
- The hepatocyte Epidermal Growth Factor Receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche 90%
- IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease 90%
- Oronasal mucosal melanoma is defined by two transcriptional subtypes in humans and dogs with implications for diagnosis and therapy 88%
Similar papers in this journal
- Tissue contamination challenges the credibility of machine learning models in real world digital pathology 90%
- MIXTURE of human expertise and deep learning—Developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease 90%
- Attention-based whole-slide image compression achieves pathologist-level pre-screening of multi-organ routine histopathology biopsies 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.